Status:
UNKNOWN
The Effect of n-3 PUFA Plant Oil Intake on Human Metabolism
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Hyperlipidemias
Eligibility:
All Genders
30-60 years
Phase:
NA
Brief Summary
The findings of previous experiments suggested that polyunsaturated fatty acids(PUFAs) has been linked to anti-hyperlipidemia, and reducing the risk of cardiovascular disease.This is a randomized doub...
Eligibility Criteria
Inclusion
- Aged between 30-60 years of age
- Marginal elevated blood lipids or hyperlipidemia\[Total cholesterol≥5.2 mmol/L(200 mg/dl) or triglyceride≥1.70 mmol/L(150mg/dl) or low density lipoprotein cholesterol≥3.4 mmol/L(130 mg/dl)\]
Exclusion
- Pregnancy；
- Known cardiovascular disease, diabetes, hypertension and any other chronic disease；
- Known gastrointestinal disease, such as Irritable Bowel Syndrome(IBS), functional bowel disease and so on；
- Acute or chronic inflammatory conditions;
- Liver or kidney dysfunction;
- An unwillingness to discontinue nutritional supplements；
- Use of lipid-lowering, antiinflammatory, antidepressant, or blood pressure medication;
- Evidence of drug or alcohol abuse；
- Take antibiotics or probiotics in the last three months.
Key Trial Info
Start Date :
June 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03484988
Start Date
June 1 2018
End Date
September 1 2019
Last Update
May 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030